Orajel 2X Medicated Gel
- Product NDC
- 10237-782
- 11-digit product format
- 102370782
- Labeler code
- 10237
- Product ID
- 10237-782_262be295-4eb0-3136-e063-6294a90a7dcc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Oral Pain Reliever
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Church & Dwight Co., Inc.
- Application
- M022
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-05-23
- Substance
- BENZOCAINE; MENTHOL
- Active strength
- 200; 2.6 mg/g; mg/g
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 10237-782 | D | Discontinued by firm | 2026-10-12 | ||
| excluded package | package | 10237-782 | 10237-782-25 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 10237-782 | 10237-782-42 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 10237-782-25 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 10237-782-42 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 10237-782-25 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 10237-782-42 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 10237-782-25 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 10237-782-42 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 10237-782-25 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 10237-782-42 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 10237-782-25 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 10237-782-42 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 10237-782-25 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 10237-782-42 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 10237-782-25 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 10237-782-42 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 10237-782-25 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 10237-782-42 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 10237-782-25 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 10237-782-42 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 10237-782-25 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 10237-782-42 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 10237-782-25 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 10237-782-42 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 10237-782-25 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 10237-782-42 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Orajel 2X Medicated Gel
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BENZOCAINE | 200 mg/g |
| MENTHOL | 2.6 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U3RSY48JW5 | Internal UNII lookup |
| L7T10EIP3A | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2117337 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 262be295-4eaf-3136-e063-6294a90a7dcc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10237-782-25 | Orajel 2X Medicated Gel | 7 g in 1 TUBE | GEL | 7 | 1 | |
| 10237-782-25 | Orajel 2X Medicated Gel | 1 in 1 CARTON | GEL | 1 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Chloraspetic | MENTHOL AND BENZOCAINE | Prestige Brands Holdings, Inc. | 2b1808b2-2574-4ab8-a762-5733251848ce | 2024-10-25 | Warnings | M022 |
| Chloraseptic Warming Sore Throat | PHENOL | Prestige Brands Holdings, Inc. | a197fab2-70ce-4a6c-9add-29d7368a75c5 | 2024-10-25 | Warnings | M022 |
| Gly-Oxide | CARBAMIDE PEROXIDE | Medtech Products Inc. | 086a0b82-e947-41c9-89e7-ba06483960c9 | 2024-10-25 | Warnings | M022 |
| CHLORASEPTIC | MENTHOL AND BENZOCAINE | Prestige Brands Holdings, Inc. | d500f423-b9f2-4d98-8f2a-8bab7c05737c | 2024-10-25 | Warnings | M022 |
| CHLORASEPTIC | MENTHOL AND BENZOCAINE | Prestige Brands Holdings, Inc. | b30e4b32-89dd-4e53-81d5-1415105361d4 | 2024-10-25 | Warnings | M022 |
| Finafta MultiOral | BENZOCAINE | Efficient Laboratories Inc. | 28c5a993-fb5f-4091-af15-32ccae4b9a7d | 2024-10-14 | Warnings | M022 |
| Rexall Sensitive Freshmint | POTASSIUM NITRATE, SODIUM FLUORIDE | Old East Main CO. | 7e715bb9-666e-4de4-ba70-1c84f5243443 | 2024-10-14 | Warnings | M022 |
| Rexall Sensitive Extra Whitening | POTASSIUM NITRATE, SODIUM FLUORIDE | Old East Main CO. | 2daf18a3-f71e-4585-8128-4663eff7eb6d | 2024-10-14 | Warnings | M022 |
| Anadent Kanka Gel | BENZOCAINE | BELMORA LLC | e0f73d78-5db1-43b4-8f58-e5410ca4560f | 2024-10-04 | Warnings | M022 |
| Listerine Cool Mint Antiseptic | EUCALYPTOL, MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE, AND THYMOL | Navajo Manufacturing Company Inc. | f5f26e2f-8a1f-4687-e053-2a95a90ae378 | 2024-10-03 | Warnings | M022 |
| Colgate Great Regular Flavor | SODIUM MONOFLUOROPHOSPHATE | Navajo Manufacturing Company Inc. | f89bf259-b738-8229-e053-6394a90a0c59 | 2024-10-03 | Warnings | M022 |
| Colgate Total SF Clean Mint | STANNOUS FLUORIDE | Navajo Manufacturing Company Inc. | f71c53e0-e2dd-16f9-e053-6394a90accff | 2024-10-03 | Warnings | M022 |
| Crest Pro Health | CETYLPYRIDINIUM CHLORIDE | Navajo Manufacturing Company Inc. | 65bf17a9-21ad-27cb-e053-2991aa0afc40 | 2024-10-02 | Warnings | M022 |
| Sensodyne Pronamel Gentle Whitening Advanced | POTASSIUM NITRATE AND SODIUM FLUORIDE | Haleon US Holdings LLC | 94e07979-943b-45bb-8e2b-90d686f3692e | 2024-09-04 | Warnings | M022 |
| Sensodyne Pronamel Gentle Whitening Advanced Plus | POTASSIUM NITRATE, SODIUM FLUORIDE | Haleon US Holdings LLC | 6eb304dd-2a24-4fa0-9d39-71264e88dd16 | 2024-08-29 | Warnings | M022 |
| Sensodyne Pronamel Clinical Enamel Strength Deep Clean | POTASSIUM NITRATE, SODIUM FLUORIDE | Haleon US Holdings LLC | cfda7efa-86fa-470d-a79f-81907e31778a | 2024-08-14 | Warnings | M022 |
| Sensodyne Pronamel Kids Bubble Twist | SODIUM FLUORIDE | Haleon US Holdings LLC | e403529a-0fac-4dab-b75c-46906add096b | 2024-08-13 | Warnings | M022 |
| Calcium Carbonate Assorted Flavors | ANTACID TABLETS | NuCare Pharmaceuticals,Inc. | af10dfb6-fef3-3410-e053-2995a90a9130 | 2024-07-17 | Warnings | M022 |
| SENSODYNE Advanced Whitening Plus | POTASSIUM NITRATE | Haleon US Holdings LLC | f757ccdd-b316-4799-a34a-10edbb73da6b | 2024-07-12 | Warnings | M022 |
| dentalux SENSITIVE ANTI-CAVITY FLUORIDE | POTASSIUM NITRATE, SODIUM FLUORIDE | Lidl US, LLC | baef7f15-8082-4e61-8c08-8beda8ad40c0 | 2024-07-03 | Warnings | M022 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2117337 | benzocaine 20 % / menthol 0.26 % Oral Gel | PSN | 262be295-4eaf-3136-e063-6294a90a7dcc | 1 |
| 2117337 | benzocaine 0.2 MG/MG / menthol 0.0026 MG/MG Oral Gel | SCD | 262be295-4eaf-3136-e063-6294a90a7dcc | 1 |
| 2117337 | benzocaine 20 % / menthol 0.26 % Oral Gel | SY | 262be295-4eaf-3136-e063-6294a90a7dcc | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 10237-782-25 | 10237078225 | 1 TUBE in 1 CARTON (10237-782-25) / 7 g in 1 TUBE | 1 tube | 2022-05-23 | No | No | Current |